Played the lead or a significant role in the development of licensing, partnering & acquisition strategies in the Assay Development, HTS, Lead Discovery, ADMET, Labeling & Detection, RNAi, Genomics, Proteomics or Molecular Biology technologies for various companies. Responsible for coordinating due diligence activities for >100 opportunities. Developed the strategic positioning and value of desired collaboration/acquisition scenarios to communicate internally and externally the specific needs and financial impact of new products & services for the short, mid, and long-term development of the associated business models.

Proven collaboration, strategic partnership, high-level multi-million dollar selling, creative negotiation and win-win deal-making skills. Developed and negotiated many types of business proposals, term sheets, contracts, and licenses for multiple companies. Responsible for a broad and diverse area of legal functions including confidentiality agreements; trademarks; and implementation of patent strategies, intellectual property process, and competitive IP/"freedom-to-operate" analyses.

Extensive experience in analyzing and segmenting highly technical markets to better determine accurate market size and growth, key players, market share, competitor strengths and weaknesses, potential gaps in products and services, game theory analyses for strategies and tactics, pricing models for penetration, etc.

Identified potential partners for a variety of business development opportunities, led correspondence with both scientific and business contacts, and developed a broad network worldwide of external contacts within multiple segments of the Life Science, genomics, pharmaceutical, biotech and agricultural industries.

Provided a leadership role for a company in the business development of 2 different “game-changing” multi-year, multi-million dollar technology collaborations with 2 different strategic partners. Managed the on-going contract terms with the Strategic Partners’ Executive Management teams with respect to all technology and products licensed within the contracts, ongoing business and commercial discussions, and operational activities between the companies to ensure success of the business relationship and the effective utilization of resources from each company (R&D, product development, manufacturing, technical/customer service support, sales & marketing).

Provided executive-level management for the business operations of a startup genomic company focusing on the Agriculture market. Developed and implemented a business strategy that would optimize the Company's revenue streams for products & services with the creation of long-term shareholders' value through creative R&D programs, sponsored research, patenting, in-licensing, out-licensing, and strategic alliances. Played a critical role in outlining various potential scenarios for operational costs and the impact of potential future revenue streams and income.

Analyzed the potential opportunity for a Life Science Company's involvement and investment in the formation of a new startup genomic company that would utilize state-of-the-art instrumentation. Responsibilities included: business plan preparation; market research; market segmentation; analysis of technology, critical licenses, and patents; product positioning; development of potential strategies and tactics; testing of business plan strategies; and identification of all critical resources needed, including facility, personnel, equipment, supplies, operational infrastructure, finances, etc.

Developed a new worldwide genomic initiative and led the strategies and tactics necessary to maximize the Company's portfolio of related products, intellectual property position, and future opportunities to achieve aggressive growth goals for the company. Executed the necessary training and implementation of critical support groups – including R&D, Manufacturing, Marketing, Sales, and Customer Service – which allowed the company to significantly penetrate new markets, including all of the top North American genome centers and companies. In the first 6 months, this initiative generated the largest revenue product launch in the history of the company.

Designed and implemented – for several companies – the marketing methodologies critical for effectively defining and positioning the value and benefit of each Company's product offerings in the market. Identified, analyzed, prioritized, recommended, and managed the negotiation process of product and technology opportunities and research agreements with multiple potential partners.

Analyzed a key technology portfolio that previously had under-performed despite having significant technical benefits. Redesigned a new comprehensive strategy to better position the technology in the marketplace and implemented the strategy worldwide. In the first year post implementation of the new strategy, the portfolio achieved Multi-million dollar success including >200% growth over the prior year and a doubling of market share in a critical market. Personally developed and closed business on >$1M of the total revenue for the portfolio through implementation of the new strategies & tactics at key accounts and established best practices that a sales team could utilize in other WW opportunities.

Analyzed the 3yr history of a multimillion dollar product portfolio from an acquired company that previously had captured majority market-share in a critical segment but which had lost the #1 position and was declining negatively by double-digit percentages annually. Quickly developed new strategies and tactics, including a comprehensive new pricing strategy, which successfully reversed the 2-yr negative trend and increased sales by a positive double-digit growth rate to regain #1 market share and a stronger presence in many key accounts worldwide.

Analyzed and developed new strategic and tactical marketing plans that would restructure and integrate various corporate divisions and product lines into a cross-functional WW Corporate Drug Discovery Initiative. Played a primary role in developing both strategic and tactical programs that would best capitalize on the resources currently available in R&D, product development, manufacturing, project management, marketing, sales, and business development across multiple divisions of the company.

Developed and implemented a Promotional Plan for a Drug Discovery Initiative that utilized specific tools for strategic and tactical goals directed at subsets of key customers in this market segment, including: Web/email campaigns (increased average monthly web-traffic >200%), Advertising (won 2 consecutive awards of advertising excellence in an industry leading journal—Drug Discovery & Development), Product flyers, Tradeshow panels/promos, Customer Surveys, and Pricing/Quoting models. Prepared WW sales training material and support tools on an on-going basis for the organization which successfully helped close business at every account targeted.

Developed commercial and operational plans for an early phase bio-informatics start-up company. Responsibilities included: performing in-depth market evaluations and developing the corresponding strategies and tactics required to penetrate the desired target markets/customers, creating a variety of sales and marketing tools to complement specific commercial activities and corporate goals, and successfully launching the technology and products into new and/or existing markets.

Developed sales, marketing, and PR strategies that focused on strengthening a Company’s corporate image externally. Met with venture capitalists and senior business development executives from other organizations to discuss strategic and financial alliances. Provided a liaison role to the Company’s Scientific Advisory Board to facilitate the sharing of ideas and information to promote business opportunities.

Developed a sales strategy for a new high-throughput drug discovery platform technology. In the first 9 months, successfully achieved and exceeded aggressive growth goals for the technology portfolio. Designed and implemented new strategies and tactics for commercializing the portfolio that were used in best practice programs throughout the world.

Identified and helped develop better internal operational systems at multiple companies for linking Business Development, Sales, Marketing, R&D, Manufacturing, Engineering, and Customer support programs critical for supporting and growing technology-driven platform portfolios.

Formulated growth strategies with the Directors of a world-class Genome Center and identified the best implementation of resources and new procedures to improve operational planning, communication, materials management, productivity, throughput, cost management, and community awareness. Developed methods for cost accounting, including determining accurate total costs for finished product to enable maximal use of funds.

Responsible for leading a world-class Genome Center's project for the design and move to a new 35,000 sq. ft. facility that was successfully completed in only 5.5 months, and which limited overall production downtime to a mere 2 days. The project involved direct responsibilities for the following: planning and coordinating all critical building designs; liaising with contractors and subcontractors on specific details of the execution; identifying, budgeting, and purchasing all equipment needed for the building and for each department's specific needs; hiring administrative staff; communicating with the Institute on progress and ongoing new critical needs along with the corresponding budget implications; motivating the team to meet appropriate milestones; and managing all details of the overall process.

Responsible – as a member of a small team – for the complete transfer (resulting from an acquisition) of all PCR manufacturing operations and all related products from CA to NJ. Participated in all areas of manufacturing operations, such as development, scheduling, inventory, purifications, formulations, bottling, QC, and QA to better understand the intricacies involved between functional groups. Focused on method development of existing products, technology-transferred products, and manufacturing operations.